Albireo Pharma EBITDA Margin 2010-2022 | ALBO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Albireo Pharma (ALBO) over the last 10 years. The current EBITDA margin for Albireo Pharma as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.06B | $-0.11B | -191.38% |
| 2022-06-30 | $0.05B | $-0.12B | -221.15% |
| 2022-03-31 | $0.05B | $-0.11B | -241.30% |
| 2021-12-31 | $0.04B | $-0.11B | -270.73% |
| 2021-09-30 | $0.01B | $-0.12B | -1100.00% |
| 2021-06-30 | $0.01B | $-0.11B | -1211.11% |
| 2021-03-31 | $0.01B | $-0.10B | -1055.56% |
| 2020-12-31 | $0.01B | $-0.09B | -944.44% |
| 2020-09-30 | $0.01B | $-0.07B | -566.67% |
| 2020-06-30 | $0.01B | $-0.07B | -590.91% |
| 2020-03-31 | $0.01B | $-0.07B | -660.00% |
| 2019-12-31 | $0.01B | $-0.05B | -577.78% |
| 2019-09-30 | $0.00B | $-0.07B | -1625.00% |
| 2019-06-30 | $0.00B | $-0.06B | -1900.00% |
| 2019-03-31 | $0.00B | $-0.05B | -1666.67% |
| 2018-12-31 | $0.01B | $-0.04B | -292.31% |
| 2018-09-30 | $0.01B | $-0.03B | -250.00% |
| 2018-03-31 | $0.01B | $-0.02B | -172.73% |
| 2017-12-31 | $0.00B | $-0.02B | inf% |
| 2017-06-30 | $0.00B | $-0.02B | -766.67% |
| 2017-03-31 | $0.01B | $-0.02B | -136.36% |
| 2016-12-31 | $0.01B | $-0.01B | -100.00% |
